Literature DB >> 7325638

Comparison of vancomycin disposition in rats with normal and abnormal renal functions.

M S Engineer, D H Ho, G P Bodey.   

Abstract

Vancomycin levels in the tissues and urine of rats with renal damage were compared with those of control rats. Renal damage was induced by a single intravenous injection of uranyl nitrate. After 5 days, when the plasma urea nitrogen levels had increased 7- to 22-fold, a single intraperitoneal vancomycin injection of 10 mg/kg yielded significantly higher plasma and tissue levels in these rats than in the control rats that did not receive uranyl nitrate. At 73 h after the vancomycin injection, the plasma vancomycin concentration in the rats with renal damage was 1.8 +/- 1.1 microgram/ml (mean +/- standard deviation), whereas in control rats the level had fallen to 0.004 +/- 0.002 microgram/ml. Control rats excreted 50.5% of a single dose in the urine within the 3 days, whereas rats with renal damage excreted only 35.6%. These results indicate that vancomycin pharmacokinetics is affected by renal function in rats. Therefore, the drug should be used very cautiously in patients with impaired renal function. The serum levels must be monitored, and the frequency and size of doses may have to be reduced.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7325638      PMCID: PMC181788          DOI: 10.1128/AAC.20.6.718

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Ototoxicity of neomycin and other antibiotics.

Authors:  W LEACH
Journal:  J Laryngol Otol       Date:  1962-10       Impact factor: 1.469

2.  Effect of prophylactic measures on the microbial flora of patients in protected environment units.

Authors:  G P Bodey; B Rosenbaum
Journal:  Medicine (Baltimore)       Date:  1974-05       Impact factor: 1.889

3.  Critical bleeding and plasma volumes of the adult germfree rat.

Authors:  C E Yale; J B Torhorst
Journal:  Lab Anim Sci       Date:  1972-08

4.  Uranyl nitrate-induced acute renal failure in the rat: micropuncture and renal hemodynamic studies.

Authors:  W Flamenbaum; M L Huddleston; J S McNeil; R J Hamburger
Journal:  Kidney Int       Date:  1974-12       Impact factor: 10.612

5.  Sensitive bioassay for vancomycin.

Authors:  C A Walker; B Kopp
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

6.  Inhibition by uranyl nitrate of adenosine triphosphatases derived from animal and human tissues.

Authors:  B R Nechay; J D Thompson; J P Saunders
Journal:  Toxicol Appl Pharmacol       Date:  1980-05       Impact factor: 4.219

7.  Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations.

Authors:  K B Crossley; J C Rotschafer; M M Chern; K E Mead; D E Zaske
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

8.  Pharmacokinetic studies of propoxyphene IV: Effect of renal failure on systemic clearance in rats.

Authors:  S M Roberts; G Levy
Journal:  J Pharm Sci       Date:  1980-03       Impact factor: 3.534

9.  Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis.

Authors:  D D Lindholm; J S Murray
Journal:  N Engl J Med       Date:  1966-05-12       Impact factor: 91.245

Review 10.  Vancomycin revisited.

Authors:  F V Cook; W E Farrar
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

View more
  5 in total

1.  Interspecies scaling for the prediction of drug clearance in children: application of maximum lifespan potential and an empirical correction factor.

Authors:  Iftekhar Mahmood
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

2.  Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure.

Authors:  S H Kim; H J Shim; W B Kim; M G Lee
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  Determination of vancomycin in human serum by high-pressure liquid chromatography.

Authors:  F Jehl; C Gallion; R C Thierry; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 5.  Scaling basic toxicokinetic parameters from rat to man.

Authors:  K Bachmann; D Pardoe; D White
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.